Linked Life Data

7907186

Source:http://linkedlifedata.com/resource/pubmed/id/7907186

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1994-4-1
pubmed:abstractText
Numerous works are devoted to the search for new classes of medication with the goal of promoting more efficacious and better tolerated drugs. Besides long-acting beta-2-adrenergic stimulants which are undergoing commercial development and whose indications are yet to be defined, one can distinguish several therapeutic classes which are undergoing research and development. Specific phosphodiesterase inhibitors of smooth bronchial muscle would have similar effects to theophylline with reduced side-effects. The potassium channel openers have a very powerful broncho-dilator action but the molecules studied are not specific for the bronchi and still have too many side-effects. Antagonists of tachykinins open research avenues in physiopathology and may have a therapeutic application. Anti-leukotrienes by their anti-inflammatory effect, would have a steroid sparing effect.
pubmed:language
fre
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0761-8425
pubmed:author
pubmed:issnType
Print
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
509-17
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1993
pubmed:articleTitle
[Novelties and perspectives in asthma medicines].
pubmed:affiliation
Laboratoire de Pharmacologie, Faculté de Médecine Paris Ouest.
pubmed:publicationType
Journal Article, English Abstract, Review